Table 1 Patient characteristics – cardiovascular
All (n = 26) | Possible (n = 6) | Probable (n = 9) | Definite (n = 11) | P | P (Pos vs Pro) | P (Pos vs Def) | P (Pro vs Def) | |
|---|---|---|---|---|---|---|---|---|
Age at clinical diagnosis (yr) | 64 ± 12 | 65 ± 8 | 63 ± 9 | 65 ± 16 | 0.904 | |||
Sex | ||||||||
Female | 10 (38) | 1 (17) | 4 (44) | 5 (45) | 0.999 | 0.333 | 0.637 | |
Male | 16 (62) | 5 (83) | 5 (56) | 6 (55) | ||||
Race | ||||||||
Black or African American | 3 (12) | 0 | 2 (22) | 1 (9) | 0.486 | 0.999 | 0.566 | |
White, non-Hispanic | 23 (88) | 6 (100) | 7 (78) | 10 (91) | ||||
Cardiovascular Risk Factors | ||||||||
History of smoking | 17 (65) | 6 (100) | 2 (22) | 9 (82) | 0.0070 | 0.515 | 0.0216 | |
Hypertension | 19 (73) | 4 (67) | 8 (89) | 7 (64) | 0.525 | 0.999 | 0.319 | |
Diabetes mellitus | 6 (23) | 1 (17) | 3 (33) | 2 (18) | 0.604 | 0.999 | 0.617 | |
Coronary Artery Disease | 12 (46) | 3 (50) | 2 (22) | 7 (64) | 0.329 | 0.645 | 0.092 | |
Prior Cardiomyopathy (any) | 8 (31) | 3 (50) | 1 (11) | 4 (36) | 0.559 | 0.999 | 0.282 | |
Stroke | 2 (8) | 0 | 0 | 2 (18) | 0.999 | 0.515 | 0.479 | |
Cardiovascular Medications | ||||||||
Statin | 11 (42) | 3 (50) | 3 (33) | 5 (45) | 0.622 | 0.999 | 0.670 | |
Aspirin | 15 (58) | 4 (67) | 4 (44) | 7 (64) | 0.608 | 0.999 | 0.653 | |
Beta-blockers | 13 (50) | 5 (83) | 1 (11) | 7 (64) | 0.0110 | 0.600 | 0.0281 | |
RAAS inhibitors | 18 (69) | 6 (100) | 5 (56) | 7 (64) | 0.103 | 0.237 | 0.999 | |